PT Murni Sadar Tbk

PT Murni Sadar Tbk

MTMH · JK · Healthcare / Medical Care Facilities

855.00IDR+5.00 (+0.59%)

Price History

Full chart

Market Stats

Previous Close850.00
Open855.00
Day Range855.00 – 855.00
52-Week Range842.98 – 1,631.08
Volume100
Market Cap1.95T
P/E (TTM)40.65
Forward P/E0.00
EPS23.25
Dividend Yield0.26%
Beta0.19
50-Day Avg944.80
200-Day Avg1,008.20

About

PT Murni Sadar Tbk, together with its subsidiaries, provides health services and manages private hospitals in Indonesia. The company offers outpatient installation services, including specialist, family health, general, dental, tropical diseases, travel medicine, and pain clinics; laboratory services, such as clinical pathology, blood bank, biomolecular/PCR, microbiology, and anatomical pathology; radiotherapy, consists of LINAC, CT-simulator and immobilization, treatment planning system, and brachytherapy services. It also provides radiology services, including general X-Ray, ultrasonography (USG), mammography, 128 slice CT scan, 1.5 Tesla MRI, and interventional radiology; heart & vascular center, such as ECG, treadmill test, echocardiology, holter monitoring, and cardiac catheterization laboratory; endoscopy, contain esophagoscopy, gastroscopy, colonoscopy, bronchoscopy, and ERCP; medical rehabilitation, comprising physiotherapy, speech and occupation therapy, and orthotic prosthetic. In addition, the company offers general services, which includes emergency installation, and inpatient facility; intensive care; public facilities; operating theatres, ESWL, laporoscopic surgery, oncology, chemotherapy, pharmaceutical installations, medical checkup, lifestyle clinic, murni teguh IVF, home care, palliative care, EEG, EMG, and ambulance services; as well as operates IVF Centre. Further, it provides general facilities such as, auditorium, cafeteria, commercials area, fitness gym, and homestay. PT Murni Sadar Tbk was founded in 2010 and is based in Medan, Indonesia.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEODr. . Mutiara M.H.A.
  • Employees4.10K
  • HeadquartersJalan Jawa No. 2, LK II, Medan, Indonesia, 20231, Indonesia
  • Websitehttps://www.rsmurniteguh.com

Leadership

  • Dr. . Mutiara M.H.A.President Director · b. 1960
  • Mr. . JohanHead of Internal Audit Unit · b. 1979
  • Mr. Armen ChandraCorporate Secretary · b. 1965

Financials

Income Statement

Currency: IDR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue340.72B443.65B568.78B983.16B822.29B921.91B1.07T1.36T
Growth (%)-+30.21%+28.21%+72.86%-16.36%+12.12%+15.82%+27.17%
Cost of Revenue263.18B355.57B400.86B557.70B604.38B697.30B797.78B1.03T
Gross Profit77.54B88.08B167.91B425.46B217.91B224.61B270.00B327.88B
Gross Margin22.76%19.85%29.52%43.28%26.50%24.36%25.29%24.15%
Operating Expense65.60B124.01B112.75B123.84B105.39B209.41B247.98B211.98B
Operating Income11.94B-35.94B55.16B301.63B112.52B15.21B22.02B115.90B
Operating Margin3.51%-8.10%9.70%30.68%13.68%1.65%2.06%8.54%
EBITDA22.99B-16.53B114.30B300.94B227.09B80.11B199.91B288.39B
EBITDA Margin6.75%-3.73%20.10%30.61%27.62%8.69%18.72%21.24%
Net Income-8.44B-85.60B2.50B130.36B65.96B-12.83B5.18B43.62B
Net Income Margin-2.48%-19.30%0.44%13.26%8.02%-1.39%0.49%3.21%
Interest Expense24.20B44.83B42.32B41.70B34.25B37.25B46.14B54.11B
Interest Expense % of Total Revenue7.10%10.10%7.44%4.24%4.17%4.04%4.32%3.98%

Balance Sheet

Currency: IDR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets775.25B876.81B805.63B1.33T1.65T1.86T2.38T2.65T
Total Liabilities683.07B826.81B755.14B577.55B502.26B708.75B956.53B1.13T
Total Equity82.06B29.06B42.33B741.12B1.13T1.12T1.38T1.48T
Cash1.02B437.50M956.46M76.14B33.05B4.95B10.69B22.31B
Total Debt596.02B724.75B639.35B377.16B362.69B495.03B658.11B769.47B
Net Debt595.00B724.31B638.40B301.02B329.65B490.08B647.42B747.15B

Cash Flow

Currency: IDR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-8.44B10.23B129.00B283.70B65.96B170.82B210.83B257.47B
Investing Cash Flow-306.69B-139.54B-43.63B-366.61B-146.41B-308.18B-352.94B-352.16B
Financing Cash Flow288.49B128.73B-85.39B272.26B-62.10B109.26B147.85B106.31B
Capital Expenditure357.63B167.60B40.34B199.29B128.00B269.78B281.10B352.14B
Free Cash Flow-366.07B-157.37B88.66B84.41B-62.04B-98.96B-70.27B-94.67B
FCF to OCF4336.16%-1538.94%68.73%29.75%-94.07%-57.93%-33.33%-36.77%

Earnings

Report DateJun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023
EPS Estimate-----
EPS Actual3.290.6012.571.26-5.54
Surprise-----
Timing-----

Key Statistics & Ratios

Market Cap1.95T
Enterprise Value2.83T
Trailing P/E40.65
Forward P/E0.00
Price / Sales1.30
Price / Book1.26
EPS23.25
Book Value740.60
Revenue (TTM)1.51T
Gross Profit (TTM)433.64B
EBITDA313.70B
Profit Margin3.20%
Operating Margin12.05%
Return on Equity3.16%
Return on Assets2.97%
Shares Outstanding2.07B
Shares Float465.36M
Beta0.19
Dividend Yield0.26%
Dividend Rate2.42
Payout Ratio10.40%

Dividends

20261×
2.42Jun 24, 2026